Furthermore, in zebrafish and murine xenograft models of rhabdomyosarcoma, treatment with HDAC inhibitors recapitulates the HDAC-loss-of-function phenotype with reduced cancer stemness and self-renewal [68]. This evidence concerns the gene HDAC9 and cancer.